What is the recommended management for a patient with a subdural hematoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Subdural Hematoma

For acute traumatic subdural hematomas requiring surgical evacuation, institute ICP monitoring postoperatively if any single criterion is met: GCS motor ≤5, pupillary abnormalities, hemodynamic instability, compressed basal cisterns, midline shift >5mm, or intraoperative cerebral edema 1.

Initial Decision: Surgical vs. Conservative Management

Immediate Surgical Indications

Proceed directly to surgery for:

  • Acute SDH >10mm thickness
  • Midline shift >5mm
  • Rapidly deteriorating neurological exam
  • Unilateral or bilateral fixed dilated pupils
  • Extensor posturing

These patients require urgent craniotomy with clot evacuation, often necessitating craniectomy for significant mass effect and cerebral edema 2.

Chronic SDH Surgical Approach

For chronic subdural hematomas, burr-hole craniostomy is the first-line surgical treatment 3, 4. The evidence strongly supports this:

  • Burr-hole drainage shows equivalent outcomes to bedside twist-drill drainage (no significant difference in mortality RR 0.69, morbidity RR 0.45, cure rates, or recurrence) 3
  • Burr-hole craniostomy can be performed under conscious sedation or general anesthesia
  • Always place subdural drains - this reduces recurrence rates by 54% (RR 0.46, P=0.002) 3
  • Use warm saline irrigation (37°C) intraoperatively to reduce recurrence 5

Postoperative ICP Monitoring Algorithm

After evacuating any traumatic intracranial hematoma (subdural, epidural, or intraparenchymal), monitor ICP if any one of these criteria exists 1:

  1. Preoperative GCS motor response ≤5
  2. Preoperative anisocoria or bilateral mydriasis
  3. Preoperative hemodynamic instability
  4. Preoperative imaging severity signs:
    • Compressed basal cisterns
    • Brain midline shift >5mm
    • Other intracranial lesions present
  5. Intraoperative cerebral edema
  6. Postoperative new intracranial lesions on imaging

ICP Monitoring Device Selection

Use intraparenchymal probes over intraventricular drains when ICP monitoring is indicated 1. The risk-benefit analysis favors intraparenchymal devices:

  • Intraventricular drains: 10% placement failure, 10% infection, 2-4% hemorrhage
  • Intraparenchymal probes: 2.5% infection, 0-1% hemorrhage

Cerebral Perfusion Pressure Management

Maintain CPP between 60-70 mmHg in the absence of multimodal monitoring 1.

Key technical points:

  • Measure MAP at the external ear tragus as the reference point
  • Do NOT routinely target CPP >70 mmHg - this increases respiratory distress syndrome 5-fold without improving neurological outcomes

Management of Recurrent or Complex CSDH

When Initial Burr-Hole Fails

Craniotomy is superior for managing recurrent CSDH (RR 0.22 for subsequent recurrence, P=0.003) 3. Reserve craniotomy for:

  • Recurrence after initial burr-hole drainage
  • Complex CSDH with prominent septations
  • Large hematomas with organized membranes
  • Acute SDH with significant mass effect

Emerging Alternative: Middle Meningeal Artery Embolization

MMA embolization is increasingly used as adjunctive or stand-alone treatment for chronic SDH 6, 5. Consider this for:

  • High-risk surgical candidates
  • Inoperable patients
  • Adjunct to reduce recurrence in complex cases

Recent randomized trials demonstrate safety and efficacy in reducing recurrence rates by occluding neomembrane vascular supply 5.

Critical Pitfalls to Avoid

Do NOT use corticosteroids - they increase morbidity (RR 1.97, P=0.005) without improving cure or recurrence rates 3.

Do NOT omit drain placement - this single intervention cuts recurrence nearly in half 3.

Do NOT perform craniotomy as initial treatment for uncomplicated chronic SDH - it carries higher complication rates (RR 1.39, P=0.01) compared to burr-hole drainage 3.

For acute traumatic SDH, recognize that 50-70% develop postoperative intracranial hypertension, and >40% will have uncontrollable ICP 1. This justifies aggressive ICP monitoring in the presence of any severity criteria.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.